Gender, PD Dose, and Anemia
Do gender and PD adequacy matter in anemia treatment, wondered researchers? Yes, as it turned out. A two-part study first included 2,180 prevalent PD patients, then followed 88 new PD patients for 3 years, recording data once a year. Regardless of adequacy, women had lower hemoglobin levels than men at every point—even with higher ESA doses.
Read the abstract » | (added 01/09/2017)